Busulfan Pharmacogenetics and Drug Exposure in Cancer Patients Undergoing Hematopoietic Stem Cell Transplantation

被引：0
|
作者：
Patel, Jai N.
Hamadeh, Issam
Zhang, Qing
Brown, Taylor
Steuerwald, Nury M.
Hamilton, Alicia
Druhan, Lawrence J.
He, Jiaxian
Symanowski, James T.
Hussain, Mohammed J.
Trivedi, Jigar
Grunwald, Michael Richard
Ghosh, Nilanjan
Avalos, Belinda Rene
Copelan, Edward A.
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3215
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Pharmacokinetics Of a Generic Formulation Of Intravenous Busulfan (BUCELON 60™) In Patients Undergoing Hematopoietic Stem Cell Transplantation
    Mohanan, Ezhilpavai
    Desire, Salamun
    Mani, Sathya
    Srinivasan, Gopinath
    George, Biju
    Mathews, Vikram
    Srivastava, Alok
    Balasubramanian, Poonkuzhali
    BLOOD, 2013, 122 (21)
  • [22] Busulfan monitoring in hematopoietic stem cell transplantation
    Queraltó, J
    Carrascosa, C
    Peña, C
    Turà, M
    Farré, R
    CLINICA CHIMICA ACTA, 2005, 355 : S423 - S424
  • [23] Therapeutic salivary monitoring of IV busulfan in patients undergoing hematopoietic stem cell transplantation: a pilot study
    L M Bezinelli
    F P Eduardo
    D L C de Carvalho
    C E dos Santos Ferreira
    E V de Almeida
    L R Sanches
    I Esteves
    P V Campregher
    N Hamerschlak
    L Corrêa
    Bone Marrow Transplantation, 2017, 52 : 1384 - 1389
  • [24] Population pharmacokinetics of Busulfan and its metabolite sulfolane in patients with myelofibrosis undergoing hematopoietic stem cell transplantation
    Dadkhah, A.
    Wicha, S. G.
    Kroeger, N.
    Mueller, A.
    Badbaran, A.
    Fehse, B.
    Langebrake, C.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 450 - 450
  • [25] Population Pharmacokinetics of Busulfan and Its Metabolite Sulfolane in Patients with Myelofibrosis Undergoing Hematopoietic Stem Cell Transplantation
    Dadkhah, Adrin
    Wicha, Sebastian Georg
    Kroeger, Nicolaus
    Mueller, Alexander
    Pfaffendorf, Christoph
    Riedner, Maria
    Badbaran, Anita
    Fehse, Boris
    Langebrake, Claudia
    PHARMACEUTICS, 2022, 14 (06)
  • [26] Home administration of high-dose oral busulfan in patients undergoing hematopoietic stem cell transplantation
    R H Matthews
    M Emami
    D G Connaghan
    H K Holland
    L E Morris
    Bone Marrow Transplantation, 2007, 39 : 397 - 400
  • [27] Home administration of high-dose oral busulfan in patients undergoing hematopoietic stem cell transplantation
    Matthews, R. H.
    Emami, M.
    Connaghan, D. G.
    Holland, H. K.
    Morris, L. E.
    BONE MARROW TRANSPLANTATION, 2007, 39 (07) : 397 - 400
  • [28] Can the pharmacogenetics of GST gene polymorphisms predict the dose of busulfan in pediatric hematopoietic stem cell transplantation?
    Ansari, Marc
    Krajinovic, Maja
    PHARMACOGENOMICS, 2009, 10 (11) : 1729 - 1732
  • [29] Drug-drug interactions in patients undergoing hematopoietic stem cell transplantation: systematic review
    Saez-Garrido, Maria
    Espuny-Miro, Alberto
    Ruiz-Gomez, Agustina
    Sacramento Diaz-Carrasco, Maria
    FARMACIA HOSPITALARIA, 2021, 45 (04) : 184 - 192
  • [30] Population pharmacokinetic of oral busulfan in Japanese undergoing hematopoietic stem cell transplantation.
    Sasaki, N
    Ogata, K
    Yamauchi, K
    Takamatsu, Y
    Suzumiya, J
    Tamura, K
    Yukawa, E
    Hara, S
    Ono, N
    BLOOD, 2005, 106 (11) : 414B - 414B
12345